This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • GDC-0449 in Treating Patients With High-Risk First...
Clinical trial

GDC-0449 in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma Who Received an Autologous Stem Cell

Read time: 1 mins
Last updated:5th Apr 2011
This phase I trial is studying how well GDC-0449 works in treating patients with high-risk first remission or relapsed multiple myeloma who received an autologous stem cell transplant.
Category Value
Study start date 2011-04-05

View full details